NewAmsterdam Pharma Co N.V. (NAMS) stock
NAMSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NAMSW
$19.39−0.07 (-0.36%)
Close on Nov 17, 2026Market cap $2.32BP/E –Yield –
NewAmsterdam Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
NewAmsterdam Pharma's price to sales ratio was 342.3× on Nov 11, 2026, against 132.6× a year earlier. Over the last 4 years it ranged from 7.1× to 418.7×, with a median of 70.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 342.3× | +229.7 |
| 2025 | Dec 31, 2025 | 112.7× | +42.1 |
| 2024 | Dec 31, 2024 | 70.5× | +61.6 |
| 2023 | Dec 29, 2023 | 8.9× | – |
See a number that looks wrong?